Call for papers: Cell and molecular therapy for cardiovascular disorders
Published in Healthcare & Nursing and General & Internal Medicine
BMC Cardiovascular Disorders is calling for submissions to our Collection on cell and molecular therapy for cardiovascular diseases. Scientists from around the globe are investigating/leveraging cell and molecular-based strategies to protect, regenerate, replace, and restore the function of cardiac and vascular tissue. Advances in basic and clinical research have yielded encouraging findings highlighting the promise of such strategies to treat a range of CVDs. However, gaps in our knowledge remain and further research is required to translate findings from basic research into the clinic.
In support of SDG 3: Good Health & Wellbeing, BMC Cardiovascular Disorders calls for papers exploring the potential of stem cells, gene editing, tissue engineering, disease modeling, and organoids to improve our understanding of cardiovascular diseases and open new avenues for therapeutic intervention.
Meet the Guest Editors
Sherin Saheera: University of Massachusetts Chan Medical School, USDr Sherin Saheera completed her PhD in India in 2017 and went to the US to pursue her postdoctoral studies. After a year of training at the University of Alabama at Birmingham, she is currently working as a Postdoctoral Associate at the University of Massachusetts, Chan Medical School, where she has been since January 2019. She has over 18 publications in peer reviewed high impact journals and has been serving as an editorial board member and reviewer for reputed journals. She has also presented papers in several national and international conferences.
Huiliang Zhang: University of Arkansas for Medical Sciences, US
Dr Zhang’s research focuses on cardiac dysfunction in the aging heart with an emphasis on the pathogenic role of elevated proton leak from mitochondria. He explores the strategies for restoring mitochondrial function and stem cell therapies to reverse cardiac dysfunction in preclinical models of aging. Dr. Zhang is the principal investigator of the NIH R35 grant and the American Heart Association (AHA) Career Development Award. Dr. Zhang served in NIH and AHA study sections. He has nearly 40 original publications and has won several national trainee and junior faculty awards.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Cell and molecular therapy for cardiovascular disorders" from the dropdown menu.Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 21 June 2024
Follow the Topic
-
BMC Cardiovascular Disorders
This journal is an open access, peer-reviewed journal that considers articles on the characterization, prevention, diagnosis and treatment of disorders of the heart and circulatory system.
Related Collections
With Collections, you can get published faster and increase your visibility.
Social and economic factors in cardiovascular disease and disorders
BMC Cardiovascular Disorders is calling for submissions to our Collection, Social and economic factors in cardiovascular disease and disorders. Cardiovascular diseases (CVDs) remain a leading cause of morbidity and mortality worldwide, with a significant proportion of their burden in low- and middle-income countries and attributable to social and economic factors. This Collection aims to explore how social and economic variables such as income, education, employment status, healthcare infrastructure and social support systems contribute to the prevalence and outcomes of cardiovascular disorders. By understanding these factors and limitations, we can better address the disparities in health outcomes experienced by different populations towards developing targeted policy changes.
Topics of interest for this Collection include but are not limited to:
-The role of socioeconomic status in cardiovascular health
-Social determinants of cardiovascular disease risk
-Access to healthcare and cardiovascular outcomes
-Interventions addressing health disparities in CVD
-Guideline adaptation for limited-resource settings
This Collection supports and amplifies research related to SDG 1: No Poverty, SDG 3: Good Health and Well Being, SDG 8: Decent work and economic growth, and SDG 10: Reduced Inequalities.
Publishing Model: Open Access
Deadline: Jul 30, 2026
Surgical advancements in cardiology
BMC Cardiovascular Disorders is calling for submissions to our Collection on Surgical advancements in cardiology. The field of cardiology has witnessed remarkable progress in surgical interventions over the past few decades, transforming the landscape of cardiovascular care. Innovations in techniques, technologies, and devices have enabled clinicians to perform complex heart surgeries with increased precision and reduced recovery times. Minimally invasive procedures, robotic-assisted surgeries, and advanced imaging modalities are just a few examples of how surgical practice in cardiology has evolved. As we continue to understand the intricacies of cardiovascular diseases, it is imperative to examine the various surgical advancements that have emerged, along with their implications for patient outcomes.
Research in this area is crucial, as advancements in heart surgery not only improve survival rates but also enhance the quality of life for patients suffering from cardiovascular conditions. The introduction of new materials, such as bioresorbable stents and grafts, and techniques like transcatheter valve replacement has revolutionized the way we approach heart disease. Moreover, understanding the risks and benefits associated with these innovations is vital to guiding clinical decision-making and ensuring patient safety.
As research in surgical advancements continues to progress, we can anticipate further breakthroughs that could redefine cardiovascular treatment. Future developments may include the integration of artificial intelligence in surgical planning and execution, personalized surgical techniques tailored to individual patient anatomy, and improved biocompatibility of devices. These advances hold the promise of enhancing surgical outcomes, minimizing complications, and ultimately paving the way for more effective and safer treatments in cardiology.
Topics of interest include but are not limited to:
-Innovations in minimally invasive heart surgery
-Robotic-assisted surgical techniques in cardiology
-Evaluating risks associated with surgical interventions
-Alternatives to traditional heart surgery
Publishing Model: Open Access
Deadline: Mar 12, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in